Teen HIV education and self-testing program in Yogyakarta
Part of Immune system & allergy, Infections clinical trials.
This study tests a program that helps teens learn about HIV and encourages self-testing. It aims to empower young people with knowledge and resilience to stay healthy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 15 and 17 years old
- Live in or go to school in the Yogyakarta area
- Be enrolled in one of the participating high schools
- Have regular access to a smartphone or device with internet
- Never been diagnosed with HIV
- Get permission from a parent or guardian
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help adolescent girls and young women at high risk of HIV take PrEP consistently. It aims to improve access and adherence to PrEP, a daily pill that prevents HIV.
This study tests a program to help young men who have sex with men in Hanoi get HIV testing and PrEP (medication to prevent HIV). The goal is to see if a phone-based tool can make it easier to access these services.
This trial tests a text-messaging program to help young guys who have sex with guys stay HIV-negative. It's designed for teens and young adults who own a cell phone and can take a quick HIV test at home.
This study is testing different ways to encourage people who are at higher risk for HIV to get retested regularly. If you are HIV-negative and get tested at a participating clinic, you may be eligible.
This trial tests a digital peer-support program to help adolescents living with HIV in Ethiopia feel less stigma. It uses group chats with trained peers to share experiences and support.
This study tests ways to help young people in Uganda prevent HIV or stay healthy if they already have HIV. It offers free prevention pills or injections and care for those living with HIV.
Hear when a new Human Immunodeficiency Virus (HIV) Infection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.